KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Accounts Payables (2016 - 2025)

Precigen (PGEN) has disclosed Accounts Payables for 13 consecutive years, with $6.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Accounts Payables rose 44.95% to $6.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.3 million, a 44.95% increase, with the full-year FY2024 number at $3.5 million, up 104.58% from a year prior.
  • Accounts Payables was $6.3 million for Q3 2025 at Precigen, up from $3.9 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $6.3 million in Q3 2025 to a low of $1.7 million in Q4 2023.
  • A 5-year average of $3.8 million and a median of $3.9 million in 2025 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: plummeted 57.57% in 2023, then surged 104.58% in 2024.
  • Precigen's Accounts Payables stood at $3.1 million in 2021, then surged by 30.72% to $4.1 million in 2022, then tumbled by 57.57% to $1.7 million in 2023, then surged by 104.58% to $3.5 million in 2024, then surged by 77.34% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Accounts Payables are $6.3 million (Q3 2025), $3.9 million (Q2 2025), and $3.1 million (Q1 2025).